A small molecule PTER-selective inhibitor reduces food intake and body weight

PTER (phosphotriesterase-related) is an amidohydrolase that mediates catabolism of the anorexigenic taurine metabolite N-acetyltaurine. However, the structural basis of PTER ligand binding and catalysis remain unknown, limiting our ability to harness this pathway therapeutically. Here we solve crystal structures of a eukaryotic PTER in apo and product-bound forms. These structures uncover an unexpected pocket homology between PTER and histone deacetylase (HDAC) enzymes. We exploit this similarity to engineer a first-in-class substrate-competitive PTER inhibitor called PTERi with nanomolar potency and >100-fold selectivity for PTER over HDACs in vitro. Administration of PTERi to diet-induced obese mice reduces feeding, enhances GLP1-RA (glucagon like peptide 1 receptor agonist)-induced weight loss, and prevents weight regain after GLP1-RA discontinuation. The structure of PTER connects histone and metabolite deacetylation into a parallel conceptual framework and enables proof-of-concept data for pharmacological inhibition of PTER in obesity.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-01-28
DOI
https://doi.org/10.64898/2026.01.26.701829
Primary Topic
Aldose Reductase and Taurine
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A small molecule PTER-selective inhibitor reduces food intake and body weight

Sipei Fu, Xuchao Lyu, Jan Spaas, Stephen M. Hinshaw et al.
bioRxiv (Cold Spring Harbor Laboratory)
Aldose Reductase and Taurine
article

A small molecule PTER-selective inhibitor reduces food intake and body weight

Sipei Fu, Xuchao Lyu, Jan Spaas, Stephen M. Hinshaw, Jonathan Z. Long, Daniel Fernández, Shuliang Deng, Robert E. Gerszten, Shuke Xiao, Lushun Wang, Veronica Lynn Li, April P. Carson, Xu Shi, Tinghu Zhang, Usman Tahir, Nathanael Gray, Hlib Razumkov, Bertha A Hidalgo, Mark Benson, Charleen Adams, Wei Wei, James G Wilson, Jacob Barber
article en

Abstract

PTER (phosphotriesterase-related) is an amidohydrolase that mediates catabolism of the anorexigenic taurine metabolite N-acetyltaurine. However, the structural basis of PTER ligand binding and catalysis remain unknown, limiting our ability to harness this pathway therapeutically. Here we solve crystal structures of a eukaryotic PTER in apo and product-bound forms. These structures uncover an unexpected pocket homology between PTER and histone deacetylase (HDAC) enzymes. We exploit this similarity to engineer a first-in-class substrate-competitive PTER inhibitor called PTERi with nanomolar potency and >100-fold selectivity for PTER over HDACs in vitro. Administration of PTERi to diet-induced obese mice reduces feeding, enhances GLP1-RA (glucagon like peptide 1 receptor agonist)-induced weight loss, and prevents weight regain after GLP1-RA discontinuation. The structure of PTER connects histone and metabolite deacetylation into a parallel conceptual framework and enables proof-of-concept data for pharmacological inhibition of PTER in obesity.

bioRxiv (Cold Spring Harbor Laboratory)
University of North Carolina at Chapel Hill (US), Beth Israel Deaconess Medical Center (US), Neurosciences Institute (US), University of Alabama at Birmingham (US), Stanford University (US)
Ono Pharma Foundation, National Institutes of Health, Wu Tsai Neurosciences Institute, Stanford University
Zero hunger
Openalex Percentile: Top 76%
Aldose Reductase and Taurine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.